Abstract:Irene K Guttilla Reed Department of Biology, University of Saint Joseph, West Hartford, CT, USA Abstract: During development and the pathogenesis of certain diseases, including cancer, the epithelial–mesenchymal transition (EMT) program is activated. It is hypothesized that EMT plays a major role in tumor invasion and the establishment of distant metastases. Metastatic disease is responsible for the vast majority of cancer-related deaths, which provides a precedent for elucidating pathways that regulate EMT. EMT is defined as the transition of cells with an epithelial phenotype into cells with a mesenchymal phenotype through a series of genetic and environmental events. This leads to the repression of epithelial-associated markers, upregulation of mesenchymal-associated markers, a loss of cell polarity and adhesion, and increased cell motility and invasiveness. EMT is a reversible and dynamic process, and can be regulated by signals from the microenvironment such as inflammation, hypoxia, and growth factors or epigenetically via microRNAs. These signals modulate key EMT-associated transcription factors and effector proteins that control cellular phenotype and regulate tumor plasticity in response to changing conditions in the microenvironment and the progressive nature of cancer. Understanding the complex regulatory networks controlling EMT can provide insight into tumor progression and metastasis. Keywords: EMT, metastasis, microRNA, transcription factor, growth factor, tumor progression

[Research progress on epithelial-mesenchymal transition in cancer recurrence and metastasis].

[Research progress on the role of epithelial-mesenchymal transition in pathogenesis of endometriosis].

The research progress of epithelial-mesenchymal transition in tumor invasion and metastasis

Epithelial–mesenchymal transition in colorectal cancer metastasis: A system review

The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis

Epithelial Mesenchymal Transition in Embryonic Development, Tissue Repair and Cancer: A Comprehensive Overview

New Insights into the Epithelial-to-Mesenchymal Transition in Cancer

Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis

Research progress of epithelial-mesenchymal transformation-related transcription factors in peritoneal metastases

Heterogeneity and plasticity of epithelial-mesenchymal transition (EMT) in cancer metastasis: Focusing on partial EMT and regulatory mechanisms

Research progress in epithelial-mesenchymal transition phenomenon in lung cancer

Epithelial‐to‐mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities

dbEMT 2.0: an updated database for epithelial-mesenchymal transition genes with experimentally verified information and pre-calculated regulation information for cancer metastasis

Mechanism and regulation of epithelial–mesenchymal transition in cancer

Epigenetic Control of Epithelial-to-mesenchymal Transition and Cancer Metastasis

Progress of tumor-associated macrophages in the epithelial-mesenchymal transition of tumor

Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer

Research progress of epithelial-to-mesenchymal(-like) transition in glioblastoma

Epigenetic modification regulates tumor progression and metastasis through EMT (Review)

Epigenetic Regulation of Epithelial to Mesenchymal Transition.

Collection on reports of molecules linked to epithelial-mesenchymal transition in the process of treating metastasizing cancer: a narrative review